• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2023年10月至2024年4月期间,20个欧洲国家通过政府和非政府提供途径获取暴露前预防(PrEP)的男男性行为者(MSM)中口服PrEP的使用情况及使用长效PrEP方案的意向。

Oral PrEP use and intention to use long-acting PrEP regimens among MSM accessing PrEP via governmental and non-governmental provision pathways, 20 European countries, October 2023 to April 2024.

作者信息

Wang Haoyi, Adriaque Lozano Alejandro, Kolstee Johann, Zimmermann Hanne Ml, Tosh Jonathan, Schroeder Melanie, Appiah Ama, Jonas Kai J

机构信息

Viroscience department, Erasmus Medical Centre, Rotterdam, The Netherlands.

Department of Work and Social Psychology, Maastricht University, Maastricht, The Netherlands.

出版信息

Euro Surveill. 2025 Aug;30(34). doi: 10.2807/1560-7917.ES.2025.30.34.2500122.

DOI:10.2807/1560-7917.ES.2025.30.34.2500122
PMID:40878701
Abstract

BACKGROUNDPre-exposure prophylaxis (PrEP) provision routes across Europe differ notably between governmental and non-governmental pathways. The introduction of long-acting (LA)-PrEP may further diversify provision dynamics.AIMWe investigated disparities in PrEP access and whether access pathways determine oral PrEP use patterns and LA-PrEP intention among PrEP-experienced men who have sex with men (MSM).METHODSUsing data from 7,505 PrEP-experienced MSM from a cross-sectional survey (PROTECT; 20 European countries, October 2023-April 2024), we used latent class analysis (LCA) to identify MSM's latent socioeconomic positions (SEPs), and logistic regression to compare the likelihood of accessing governmental/non-governmental pathways, and compare oral PrEP adherence, discontinuation and LA-PrEP intention between governmental/non-governmental pathways.RESULTSMost MSM accessed PrEP via governmental pathways (n = 6,671; 88.9%), 11.1% (n = 834) used non-governmental pathways. The LCA identified three groups: employed MSM with more advantaged SEPs, younger MSM with less advantaged SEPs, and older MSM with more advantaged SEPs. Compared with the first group, younger MSM with less advantaged SEPs were significantly more likely to access PrEP via non-governmental pathways (aOR = 1.27; 95% confidence interval (CI): 1.04-1.55). Accessing PrEP via non-governmental pathways was associated with suboptimal adherence (aOR = 1.28; 95% CI: 1.03-1.58), discontinuation (aOR = 3.55; 95% CI: 2.99-4.21), but also higher LA-PrEP intention (aOR = 1.28; 95% CI: 1.06-1.56).CONCLUSIONSInequalities exist in PrEP access among MSM in Europe. While non-governmental pathways offer opportunities to engage MSM with less advantaged SEPs, oral PrEP use patterns via this pathway were not optimal. Tailored efforts should ensure that PrEP is accessible and affordable to enhance current use and prepare for future LA-PrEP modalities.

摘要

背景

在欧洲,暴露前预防(PrEP)的提供途径在政府和非政府渠道之间存在显著差异。长效(LA)-PrEP的引入可能会使提供动态进一步多样化。

目的

我们调查了有PrEP使用经验的男男性行为者(MSM)在PrEP获取方面的差异,以及获取途径是否决定口服PrEP的使用模式和对LA-PrEP的意向。

方法

利用一项横断面调查(PROTECT;20个欧洲国家,2023年10月至2024年4月)中7505名有PrEP使用经验的MSM的数据,我们使用潜在类别分析(LCA)来确定MSM的潜在社会经济地位(SEP),并使用逻辑回归来比较通过政府/非政府途径获取PrEP的可能性,以及比较政府/非政府途径之间口服PrEP的依从性、停药情况和对LA-PrEP的意向。

结果

大多数MSM通过政府途径获取PrEP(n = 6671;88.9%),11.1%(n = 834)使用非政府途径。LCA确定了三组:社会经济地位更优越的就业MSM、社会经济地位较不优越的年轻MSM以及社会经济地位更优越的年长MSM。与第一组相比,社会经济地位较不优越的年轻MSM通过非政府途径获取PrEP的可能性显著更高(调整后比值比[aOR]=1.27;95%置信区间[CI]:1.04 - 1.55)。通过非政府途径获取PrEP与依从性欠佳(aOR = 1.28;95% CI:1.03 - 1.58)、停药(aOR = 3.55;95% CI:2.99 - 4.21)相关,但对LA-PrEP的意向也更高(aOR = 1.28;95% CI:1.06 - 1.56)。

结论

欧洲MSM在PrEP获取方面存在不平等。虽然非政府途径为社会经济地位较不优越的MSM提供了参与机会,但通过该途径的口服PrEP使用模式并不理想。应采取有针对性的措施,确保PrEP可及且价格合理,以增加当前的使用并为未来的LA-PrEP模式做好准备。

相似文献

1
Oral PrEP use and intention to use long-acting PrEP regimens among MSM accessing PrEP via governmental and non-governmental provision pathways, 20 European countries, October 2023 to April 2024.2023年10月至2024年4月期间,20个欧洲国家通过政府和非政府提供途径获取暴露前预防(PrEP)的男男性行为者(MSM)中口服PrEP的使用情况及使用长效PrEP方案的意向。
Euro Surveill. 2025 Aug;30(34). doi: 10.2807/1560-7917.ES.2025.30.34.2500122.
2
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.巴西男男性行为者和跨性别女性中青少年对事件驱动型和长效注射用暴露前预防药物的知晓率及使用意愿:一项横断面研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26479. doi: 10.1002/jia2.26479.
3
Location Preferences for Accessing Long-Acting Injectable Pre-Exposure Prophylaxis (LA-PrEP) Among Men Who Have Sex With Men (MSM) Currently on Daily Oral PrEP.目前正在每日口服暴露前预防药物(PrEP)的男男性行为者(MSM)中,获取长效注射用暴露前预防药物(LA-PrEP)的地点偏好。
J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241293336. doi: 10.1177/23259582241293336.
4
Intention to Use Pre-Exposure Prophylaxis Among Age Groups of Brazilian Men Who Have Sex With Men: National Cross-Sectional Study.巴西男男性行为者各年龄组使用暴露前预防药物的意向:全国横断面研究
JMIR Public Health Surveill. 2025 Jul 8;11:e58405. doi: 10.2196/58405.
5
Differences between men who have sex with men that use drugs and engage in chemsex and those who do not engage in chemsex in the French ANRS-PREVENIR cohort: the need to rethink harm reduction services.法国国家艾滋病研究机构(ANRS)的“预防未来”队列研究中,使用毒品并参与化学性行为的男男性行为者与未参与化学性行为的男男性行为者之间的差异:重新思考减少伤害服务的必要性。
Subst Abuse Treat Prev Policy. 2025 Aug 25;20(1):33. doi: 10.1186/s13011-025-00661-x.
6
The Disparities of PrEP Adherence Among Men Who Have Sex With Men Between the Global South and the Global North: An Updated Determinantal Global Meta-Analysis.全球南方与全球北方男男性行为者中暴露前预防依从性的差异:一项最新的决定性全球荟萃分析。
J Acquir Immune Defic Syndr. 2025 May 1;99(1):1-8. doi: 10.1097/QAI.0000000000003635.
7
Optimising HIV pre-exposure prophylaxis and testing strategies in men who have sex with men in Australia, Thailand, and China: a modelling study and cost-effectiveness analysis.在中国、澳大利亚和泰国优化男男性行为者的 HIV 暴露前预防和检测策略:一项建模研究和成本效益分析。
Lancet Glob Health. 2024 Feb;12(2):e243-e256. doi: 10.1016/S2214-109X(23)00536-3.
8
Willingness to Use Long-Acting Injectable Cabotegravir and Associated Factors Among Men Who Have Sex with Men in Guangxi, China.中国广西男男性行为者使用长效注射型卡替拉韦的意愿及其相关因素。
Arch Sex Behav. 2024 Jul;53(7):2795-2806. doi: 10.1007/s10508-024-02886-6. Epub 2024 Jun 7.
9
Men's Voices on Long-Acting Pre-Exposure Prophylaxis Delivery Modalities: Acceptability and Preferences Among Cisgender Men and Men Who Have Sex With Men in South Africa.男性对长效暴露前预防给药方式的看法:南非顺性别男性和男男性行为者的可接受性及偏好
J Acquir Immune Defic Syndr. 2025 May 1;99(1):55-63. doi: 10.1097/QAI.0000000000003638.
10
Impact of changing pre-exposure prophylaxis regimens on retention among men who have sex with men in Hanoi, Vietnam (2020-2023): a cohort study.越南河内男男性行为者中暴露前预防方案变化对留存率的影响(2020 - 2023年):一项队列研究
J Int AIDS Soc. 2025 Jul;28 Suppl 2(Suppl 2):e26478. doi: 10.1002/jia2.26478.

本文引用的文献

1
Epidemiological impact and cost-effectiveness analysis of PrEP provision expansion among MSM in the Netherlands.荷兰男男性行为者中扩大暴露前预防药物供应的流行病学影响及成本效益分析
J Int AIDS Soc. 2025 Jun;28(6):e26516. doi: 10.1002/jia2.26516.
2
The Disparities of PrEP Adherence Among Men Who Have Sex With Men Between the Global South and the Global North: An Updated Determinantal Global Meta-Analysis.全球南方与全球北方男男性行为者中暴露前预防依从性的差异:一项最新的决定性全球荟萃分析。
J Acquir Immune Defic Syndr. 2025 May 1;99(1):1-8. doi: 10.1097/QAI.0000000000003635.
3
Policy Recommendations to Support Equitable Access to Long-Acting Injectables for Human Immunodeficiency Virus Prevention and Treatment: A Policy Paper of the Infectious Diseases Society of America and the HIV Medicine Association.
支持公平获取长效注射剂以预防和治疗人类免疫缺陷病毒的政策建议:美国传染病学会和艾滋病医学协会的政策文件
Clin Infect Dis. 2025 Jan 28. doi: 10.1093/cid/ciae648.
4
Missed opportunities for early HIV diagnosis in Greece: The MORFEAS study, 2019 to 2021.希腊错失早期艾滋病毒诊断机会:2019 至 2021 年 MORFEAS 研究。
Euro Surveill. 2024 Nov;29(48). doi: 10.2807/1560-7917.ES.2024.29.48.2400138.
5
Likelihood of HIV and recent bacterial sexually transmitted infections among transgender and non-binary individuals in 20 European countries, October 2023 to April 2024.2023 年 10 月至 2024 年 4 月,20 个欧洲国家跨性别和非二进制个体中 HIV 和近期细菌性性传播感染的可能性。
Euro Surveill. 2024 Nov;29(48). doi: 10.2807/1560-7917.ES.2024.29.48.2400347.
6
Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.双年度利纳卡帕韦或每日 F/TAF 用于预防 cisgender 女性中的 HIV。
N Engl J Med. 2024 Oct 3;391(13):1179-1192. doi: 10.1056/NEJMoa2407001. Epub 2024 Jul 24.
7
Intention and preference to use long-acting injectable PrEP among MSM in the Netherlands: a diffusion of innovation approach.意向和偏好使用长效注射型 PrEP 预防男男性行为者中的 HIV 感染:创新扩散方法。
AIDS Care. 2024 Jul;36(sup1):89-100. doi: 10.1080/09540121.2024.2307378. Epub 2024 May 7.
8
HIV pre-exposure prophylaxis services, provision, and delivery in the European treatment network of HIV, hepatitis and global emerging infectious diseases (NEAT ID).HIV 暴露前预防服务、供应和提供在欧洲 HIV、肝炎和全球新发传染病治疗网络(NEAT ID)中。
HIV Med. 2024 Mar;25(3):353-360. doi: 10.1111/hiv.13580. Epub 2023 Dec 1.
9
Population-level impact of expanding PrEP coverage by offering long-acting injectable PrEP to MSM in three high-resource settings: a model comparison analysis.在三个资源丰富的地区为男男性行为者提供长效注射型 PrEP 以扩大 PrEP 覆盖面的人群影响:模型比较分析。
J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26109. doi: 10.1002/jia2.26109.
10
Preparing for long-acting PrEP delivery: building on lessons from oral PrEP.准备长效 PrEP 给药:借鉴口服 PrEP 的经验。
J Int AIDS Soc. 2023 Jul;26 Suppl 2(Suppl 2):e26103. doi: 10.1002/jia2.26103.